Dissolution Technologies

Papers
(The TQCC of Dissolution Technologies is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
In Vitro Product Performance Testing of Oral Drug Products: View of the USP Expert Panel12
Evaluation of a pH-Gradient Biphasic Dissolution Test for Predicting In Vivo Performance of Weakly Basic Drugs8
Comparative Analysis of Commercially Available Acetaminophen Tablets in Saudi Arabia7
In Vitro Performance Tests for Continuous Manufacturing: The Impact on the Current Compendial Framework from the Viewpoint of the USP New Advancements in Product Performance Testing Expert Panel6
Evaluation of Critical Quality Attributes of Dapsone Gel6
Predictive Dissolution Models for Real-Time Release Testing: Development and Implementation - Workshop Summary Report5
A Novel Application of an Effervescent Agent in Naproxen Liqui-Pellets for Enhanced Drug Release5
Dissolution Profile of Apixaban Tablets: Method Development and Validation Using HPLC Analysis5
Questions and Answers May 20234
Comparison of Release Rates Derived from Cutaneous Versus Film-Forming Solution Containing Terbinafine: Approach Towards Qualification and Validation of In Vitro Parameters4
In Vitro Characterization of Multi-Source Omeprazole Capsule Dissolution Performance Under Biorelevant Conditions4
Simulated Lymphatic Fluid for In-Vitro Assessment in Pharmaceutical Development4
Questions and Answers February 20253
Comparative Study of Metformin Hydrochloride Tablets in Argentina3
Highlights from 2022 AAPS 360-In Vitro Release and Dissolution Testing Community Annual Meeting3
Rapid Development of an Accelerated In Vitro Release Method for a Novel Antibiotic-Eluting Biologic Envelope3
Questions and Answers May 20252
Questions and Answers February 20222
Dissolution Best Practices and International Harmonization - AAPS Workshop Report2
Review: Application of Bioequivalence Testing of Medicines in Peru2
Dissolution Specifications for Ibuprofen Soft Gelatin Capsules: A Proposal2
Factors Influencing the Selection of Medium for Evaluating Drug Solubility and Dissolution in Bovine Milk1
Evaluation of NanoDis as an Automated Sampling Technology for In Vitro Release Testing of Nanomedicines1
Report on the Virtual Workshop: A Quest for Biowaiver, Including Next Generation Dissolution Characterization and Modeling1
Using a Laser Monitoring Technique for Dissolution and Thermodynamic Study of Celecoxib in 2-Propanol and Propylene Glycol Mixtures1
Release Profile of Branded Atorvastatin Calcium Tablet Relative to Commercially Available Counterpart Generics1
Comparative Study of Metformin Hydrochloride Tablets in Argentina1
Dissolution Performance of Verapamil-HCl Tablets Using USP Apparatus 2 and 4: Prediction of In Vivo Plasma Profiles1
Comparative Study of Metronidazole Tablets Marketed in Saudi Arabia1
Highlights from the 2023 AAPS 360 Annual Meeting - In Vitro Release and Dissolution1
In Vitro Pharmaceutical Quality Evaluation of Loratadine Tablets in Saudi Arabia1
Questions and Answers November 20231
Evaluation of Pharmaco-Equivalence Properties of Lisinopril Dihydrate Tablets in Saudi Arabia: A Local Comparative Study1
Comparison of Rosuvastatin Calcium Tablets Marketed in Saudi Arabia Under Biowaiver Conditions: In Vitro Quality Control Dissolution Study1
Testing the In Vitro Product Performance of Inhalation and Nasal Drug Products: Views of the USP Expert Panel1
Comparative Dissolution Study of Various Brands of Valsartan Tablets Marketed in Pakistan1
0.051347970962524